Thus, our study provides a rationale to assess SEMA4A expression on GC TIL-Bs and in TLS of other virally induced cancers such as HCC, MCC, and cervical cancer where SEMA4A expression on GC TIL-Bs has not yet been reported. The gene discussed is SEMA4A; the disease is cancer.